https://yezz.co.uk/ Independent UK information about retatrutide: trial results, regulatory timeline and safety warnings. Nothing for sale. en-gb https://yezz.co.uk/no-real-retatrutide-for-sale https://yezz.co.uk/no-real-retatrutide-for-sale Fri, 11 Sep 2026 09:00:00 GMT Retatrutide is not approved for sale or use in any country. Products sold as retatrutide are unlicensed and illegal to supply for human use in the UK. https://yezz.co.uk/what-is-retatrutide https://yezz.co.uk/what-is-retatrutide Fri, 11 Sep 2026 09:00:00 GMT Retatrutide (LY3437943) is a once-weekly injectable triple agonist of GIP, GLP-1 and glucagon receptors, in development at Eli Lilly for obesity and related conditions. https://yezz.co.uk/trial-results https://yezz.co.uk/trial-results Fri, 11 Sep 2026 09:00:00 GMT Complete numeric summary of retatrutide clinical trials: Phase 2 in NEJM 2023 and the Phase 3 TRIUMPH and TRANSCEND-T2D programmes. https://yezz.co.uk/uk-approval-timeline https://yezz.co.uk/uk-approval-timeline Fri, 11 Sep 2026 09:00:00 GMT Projected UK regulatory pathway for retatrutide: FDA BLA in Q1 2027, possible MHRA authorisation around 2028, NICE appraisal and NHS access from 2029. https://yezz.co.uk/safety-and-side-effects https://yezz.co.uk/safety-and-side-effects Fri, 11 Sep 2026 09:00:00 GMT Side-effect profile of investigational retatrutide from Phase 2 and Phase 3 trials: gastrointestinal effects, heart rate, cautions and unknowns. https://yezz.co.uk/retatrutide-vs-mounjaro-vs-wegovy https://yezz.co.uk/retatrutide-vs-mounjaro-vs-wegovy Fri, 11 Sep 2026 09:00:00 GMT Comparison of retatrutide with tirzepatide (Mounjaro) and semaglutide (Wegovy), with cross-trial caveats and current UK availability. https://yezz.co.uk/price-and-nhs-access https://yezz.co.uk/price-and-nhs-access Fri, 11 Sep 2026 09:00:00 GMT No retatrutide price exists yet. Projected UK pricing based on the tirzepatide and semaglutide precedent, and current costs of authorised alternatives. https://yezz.co.uk/faq https://yezz.co.uk/faq Fri, 11 Sep 2026 09:00:00 GMT Answers to the most common UK questions about retatrutide: approval status, buying risks, timeline, efficacy, side effects and NHS access. https://yezz.co.uk/mounjaro-uk https://yezz.co.uk/mounjaro-uk Fri, 11 Sep 2026 09:00:00 GMT How to get MHRA-authorised Mounjaro safely in the UK through GPhC-registered pharmacies, typical private prices, NHS eligibility and scam red flags. https://yezz.co.uk/wegovy-uk https://yezz.co.uk/wegovy-uk Fri, 11 Sep 2026 09:00:00 GMT How to get MHRA-authorised Wegovy safely in the UK through regulated providers, typical private prices, NHS eligibility and pharmacy verification. https://yezz.co.uk/wegovy-pill-uk https://yezz.co.uk/wegovy-pill-uk Fri, 11 Sep 2026 09:00:00 GMT Oral semaglutide in the UK: how the Wegovy pill differs from the injection, who it suits, and how to buy it safely through regulated providers. https://yezz.co.uk/foundayo-uk https://yezz.co.uk/foundayo-uk Fri, 11 Sep 2026 09:00:00 GMT Foundayo (orforglipron) in the UK: how the daily small-molecule GLP-1 tablet differs from the Wegovy pill, who it suits, and how to buy it safely. https://yezz.co.uk/about https://yezz.co.uk/about Fri, 11 Sep 2026 09:00:00 GMT Who runs Yezz, how every factual claim is sourced and checked, the corrections policy, and the funding model: an information site with nothing to sell.